Muscular Dystrophy Trial, Recruiting (NCT04369209)

Muscular Dystrophy Trial, Recruiting NCT04369209 Sponsor: Ning Wang, MD., PhD. Condition: Muscular Dystrophy

Printed from Voxsanity (voxsanity.com.au) — NCT04369209 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Muscular Dystrophy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of any age and any gender may be eligible to take part.
People who have been diagnosed with FSHD1 (a specific type of muscular dystrophy) confirmed by a specialised genetic test, whether or not they currently have symptoms.
Healthy individuals who are not related to anyone with FSHD1 may also be eligible to take part as comparison participants.

Who may not be able to join:

Anyone who does not wish to take part in the trial.
People who have another type of muscle or nerve disease, such as Limb-girdle muscular dystrophy or Myotonic dystrophy.
People who have a serious illness affecting major organs or body systems, such as heart, liver, or kidney disease, or a significant mental health condition.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13805015340

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04369209

Sponsor: Ning Wang, MD., PhD.

Phase: Not Applicable

Status: Recruiting

Condition: Muscular Dystrophy

Trial contact: 13805015340

More information: https://clinicaltrials.gov/study/NCT04369209

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of any age and any gender may be eligible to take part.
People who have been diagnosed with FSHD1 (a specific type of muscular dystrophy) confirmed by a specialised genetic test, whether or not they currently have symptoms.
Healthy individuals who are not related to anyone with FSHD1 may also be eligible to take part as comparison participants.

Who may not be able to join:

Anyone who does not wish to take part in the trial.
People who have another type of muscle or nerve disease, such as Limb-girdle muscular dystrophy or Myotonic dystrophy.
People who have a serious illness affecting major organs or body systems, such as heart, liver, or kidney disease, or a significant mental health condition.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ning Wang, MD., PhD.

Registry

ClinicalTrials.gov

Start date

1 January 2001

Est. completion

1 December 2031

Where this trial is recruiting

🇨🇳 China

Primary endpoints

PFGE-based Southern blotting; The FSHD Clinical Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov